GLP-1 and Kidney Health: What Ozempic Does to Your Kidneys Good and Bad

May 24, 2026

GLP-1 and Kidney Health: What Ozempic Does to Your Kidneys (Good and Bad)

By Dr. Onikepe Adegbola, MD PhD — Johns Hopkins-trained physician-scientist and founder of Casa de Sante

Key Takeaways

GLP-1 medications have a complex relationship with kidneys. The good: weight loss and blood sugar improvement protect kidneys long-term. The risk: dehydration from nausea/vomiting can cause acute kidney injury (AKI).
The FLOW trial (2024) showed semaglutide reduced risk of kidney disease progression by 24% in patients with type 2 diabetes and chronic kidney disease. This is a major finding.
However, AKI reports have increased with GLP-1 use — primarily from severe dehydration secondary to persistent nausea, vomiting, and reduced fluid intake.
Prevention: adequate hydration (minimum 64 oz/day), slow dose titration, and monitoring kidney function (creatinine/GFR) during treatment

The Kidney Benefits

The FLOW Trial

The FLOW trial was the first dedicated kidney outcomes trial for a GLP-1 medication. Results:

24% reduction in composite kidney outcome (kidney failure, 50% reduction in GFR, kidney death)
Significant reduction in proteinuria (protein in urine — a marker of kidney damage)
Benefits observed independent of weight loss — suggesting direct kidney-protective effects

How GLP-1 Protects Kidneys

Blood pressure reduction: GLP-1 promotes natriuresis (sodium excretion), reducing blood pressure. Hypertension is the #2 cause of kidney disease.
Blood sugar improvement: Diabetes is the #1 cause of kidney disease. Better glycemic control = less kidney damage.
Weight loss: Obesity-related glomerulopathy (kidney damage from obesity alone) improves with weight loss.
Anti-inflammatory effects: GLP-1 receptors exist in the kidney. Activation reduces renal inflammation and oxidative stress.
Reduced albuminuria: GLP-1 appears to directly reduce protein leakage from damaged kidney filters.

The Kidney Risks

Acute Kidney Injury (AKI)

AKI is the primary kidney concern with GLP-1 medications. The mechanism is NOT direct kidney toxicity — it is dehydration:

GLP-1 causes nausea in 20-44% of patients
Nausea → reduced fluid intake + vomiting → dehydration
Kidneys need blood flow to function. Dehydration reduces blood volume → reduced kidney perfusion → AKI
Risk is highest during dose titration and in hot weather

Who Is At Risk

Pre-existing chronic kidney disease (CKD stage 3+)
Patients on ACE inhibitors, ARBs, or diuretics (these medications reduce kidney compensatory capacity)
Older adults (reduced thirst sensation, less renal reserve)
Hot climate / physically active (higher fluid needs)
Patients experiencing persistent nausea/vomiting on GLP-1

Protecting Your Kidneys on GLP-1

Hydration target: Minimum 64 oz (2 liters) of water per day. More if active, in heat, or experiencing nausea/vomiting. Set a timer if needed.
Report persistent nausea: If you cannot keep fluids down for more than 24 hours, contact your provider immediately. This is when AKI risk peaks.
Slow titration: The standard titration schedule exists for a reason. Don't rush to higher doses.
Monitor labs: Creatinine and GFR should be checked at baseline, at 3 months, then every 6 months while on therapy.
Electrolytes: Vomiting depletes sodium, potassium, and chloride. Consider electrolyte supplementation during periods of nausea.
NSAID avoidance: NSAIDs (ibuprofen, naproxen) reduce kidney blood flow. The combination of GLP-1-related dehydration + NSAID use is particularly dangerous for kidneys.

🛒 Kidney Health + GLP-1 Support

Daily Vitamin — Kidney-supportive micronutrients including B vitamins, vitamin D, and minerals that may be depleted during GLP-1 therapy. Deficiencies in these nutrients worsen kidney function. A comprehensive daily vitamin provides baseline nutritional insurance.
Whey Protein — Maintaining adequate protein intake is important for kidney-healthy patients on GLP-1 (note: high protein may not be appropriate for advanced CKD — consult your nephrologist). For those with normal kidney function, protein shakes help prevent the excessive muscle loss that occurs during GLP-1 weight loss.
Digestive Enzymes — Reducing nausea triggers is critical for preventing dehydration and AKI. Proper digestion means less GI distress, less nausea, better fluid tolerance, and more stable hydration — directly protecting kidney function.

Medical Disclaimer: This article is for educational purposes only. If you have chronic kidney disease, work closely with your nephrologist before starting or while taking GLP-1 medications. Signs of AKI include: sudden decrease in urine output, swelling in legs/ankles, confusion, and extreme fatigue. Seek immediate medical care for these symptoms. Dr. Adegbola is the founder of Casa de Sante.

Back to blog

Keto. Paleo. No Digestive Triggers. Shop Now

No onion, no garlic – no pain. No gluten, no lactose – no bloat. Low FODMAP certified.

Stop worrying about what you can't eat and start enjoying what you can. No bloat, no pain, no problem.

Our gut friendly keto, paleo and low FODMAP certified products are gluten-free, lactose-free, soy free, no additives, preservatives or fillers and all natural for clean nutrition. Try them today and feel the difference!